FDA Resubmission Path for Tab-cel Keeps Atara’s (ATRA) Regulatory Timeline Alive

🌐 Yahoo Finance —
FDA Resubmission Path for Tab-cel Keeps Atara’s (ATRA) Regulatory Timeline Alive

AI Summary

Atara's regulatory timeline remains intact as the FDA accepts a resubmission pathway for their product Tab-cel. This development could have significant implications for the company and its stakeholders.

Health Atara FDA Tab-cel regulatory healthcare

Read original source →